Dr. Pace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1120 15th St
Augusta, GA 30912Phone+1 706-721-6256
Education & Training
- Medical College of Wisconsin Affiliated HospitalsResidency, Pediatrics, 1981 - 1984
- Medical College of WisconsinClass of 1981
- University of ColoradoFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
- GA State Medical License 2010 - 2026
- TX State Medical License 2003 - 2011
- AL State Medical License 1994 - 2003
- WA State Medical License 1994 - 1994
- CO State Medical License 1987 - 1991
- WI State Medical License 1982 - 1987
- American Board of Pediatrics Pediatrics
Publications & Presentations
PubMed
- 18 citationsSickle cell disease: progress towards combination drug therapyBetty S. Pace, Athena Starlard-Davenport, Abdullah Kutlar
British Journal of Haematology. 2021-01-20 - 20 citationsGlobal Genetic Architecture of an Erythroid Quantitative Trait Locus, HMIP-2Stephan Menzel, Helen Rooks, Diana Zelenika, Siana Nkya Mtatiro, Akshala Gnanakulasekaran
Annals of Human Genetics. 2014-11-01 - 37 citationsMendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential.Tetsushi Nakao, Alexander G Bick, Margaret A Taub, Seyedeh M Zekavat, Md M Uddin
Science Advances. 2022-04-08
Abstracts/Posters
- Double-Blind, Randomized Study of Canakinumab Treatment in Pediatric and Young Adult Patients with Sickle Cell AnemiaClinically Relevant AbstractBetty S. Pace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Downregulation of Cytoskeletal Protein Kazrin in Lung Endothelial Cells of Preclinical Sickle Cell Disease Mouse Model - Essential Role of Endothelial Barrier FunctionBetty S. Pace, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- New Drug Boosts Foetal Haemoglobin to Fight Sickle Cell DiseaseMay 18th, 2023
- Research Program Aimed at Diversity Brings Young Scientists to MCG Through July 30, 2019July 17th, 2019
- Pace to Be Honored with Inaugural Award for Leadership in Promoting DiversityAugust 28th, 2017
- Join now to see all
Grant Support
- Gamma Globin Induction: Molecular And Cell-Based StrategiesNational Heart, Lung, And Blood Institute2011
- Pride-Functional And Applied Genomics Of Blood DisordersNational Heart, Lung, And Blood Institute2010–2011
- Gamma Globin Induction: Molecular And Cell-Based StrategiesNational Heart, Lung, And Blood Institute2008–2010
- Genome-Wide Association Study: Fetal Hemoglobin Phenotypes In Sickle Cell DiseaseNational Institute Of Diabetes And Digestive And Kidney Diseases2009
- Sickle Cell Disease Research Center (SCDRC) Summer Institute/Mentoring ProgramNational Heart, Lung, And Blood Institute2006–2009
- Mechanisms For STAT 3-Mediated Gamma-Globin Gene Silenc*National Heart, Lung, And Blood Institute2003–2006
- Mechanisms For STAT 3-Mediated Gamma-Globin Gene SilencingNational Heart, Lung, And Blood Institute2004
- Mechanisms For P38 MAP Kinase Dependentt Gene InductionNational Heart, Lung, And Blood Institute2002–2004
- Mechanisms For P38 MAP Kinase Dependentt Gene InductionNational Heart, Lung, And Blood Institute2002
- Novel Mechanism For Globin Gene Silencing During Alternate Lineage CommitmentNational Heart, Lung, And Blood Institute1998–2002
- Mechanisms For P38 MAP Kinase Dependent Gene InductionNational Heart, Lung, And Blood Institute2001
- Mechanisms Involved In The Induction Of Fetal HemoglobinNational Heart, Lung, And Blood Institute1996–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: